Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurotransmitter biosynthesis is the collective term for all molecular pathways by which nerve cells enzymatically convert precursor substrates into functional neurotransmitters such as acetylcholine, dopamine, serotonin, glutamate, and GABA[1][2][3]. This process typically involves enzymes that catalyze sequential steps: for example, tyrosine hydroxylase and aromatic amino acid decarboxylase synthesize dopamine from tyrosine, while glutamic acid decarboxylase converts glutamate to GABA. Precise neurotransmitter biosynthesis is essential for balanced neuronal communication in the central and peripheral nervous systems; disruptions can cause disorders ranging from Parkinson’s disease to depression[1][2][4][5]. However, "Neurotransmitter biosynthesis" as a term does not denote a specific druggable molecule or receptor; rather, individual enzymes in these pathways are drug targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurotransmitter biosynthesis.